CXC10 Rebrand: Qualigen (QLGN) Rockets 333.8% Pre‑Market After Faraday Future’s $41M PIPE to Build Crypto & Web3 Platform

COINOTAG News on September 22 reported that, per consolidated market data, Qualigen Therapeutics (QLGN) surged **333.8%** in pre‑market trading to $12.32; the price movement was recorded in pre‑market transactions and is reflected across market feeds.

Earlier disclosures dated September 20 indicated Faraday Future (NASDAQ: FFAI) executed a $41 million PIPE transaction to acquire a strategic stake in Qualigen Therapeutics (NASDAQ: QLGN), with plans to rename the entity CXC10 and reorient it toward a crypto and Web3 business platform, based on the reported filing.